146 related articles for article (PubMed ID: 25301919)
1. Neutropenic sepsis: a potentially life-threatening complication of chemotherapy.
Ford A; Marshall E
Clin Med (Lond); 2014 Oct; 14(5):538-42. PubMed ID: 25301919
[No Abstract] [Full Text] [Related]
2. Acute Oncology Care: A narrative review of the acute management of neutropenic sepsis and immune-related toxicities of checkpoint inhibitors.
Knight T; Ahn S; Rice TW; Cooksley T
Eur J Intern Med; 2017 Nov; 45():59-65. PubMed ID: 28993098
[TBL] [Abstract][Full Text] [Related]
3. Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice.
Kumar P; Bajpai J; Shetty N; Medekar A; Kurkure PA; Ghadyalpatil N; Gupta S; Noronha V; Kanujia A; Parikh P; Banavali SD
Indian J Cancer; 2014; 51(4):491-5. PubMed ID: 26842174
[TBL] [Abstract][Full Text] [Related]
4. FACTORS ASSOCIATED WITH TREATMENT OUTCOME OF PEDIATRIC CANCERPATIENTS ADMITTED WITH FEBRILE NEUTROPENIA IN TIKURANBESSA SPECIALIZED TEACHING HOSPITAL, ADDIS ABABA, ETHIOPIA.
Assefa S; Alemayehu T; Abebe W
Ethiop Med J; 2017 Jan; 55(1):43-7. PubMed ID: 29148638
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the MASCC and CISNE scores for identifying low-risk neutropenic fever patients: analysis of data from three emergency departments of cancer centers in three continents.
Ahn S; Rice TW; Yeung SJ; Cooksley T
Support Care Cancer; 2018 May; 26(5):1465-1470. PubMed ID: 29168032
[TBL] [Abstract][Full Text] [Related]
6. Current management of chemotherapy-induced neutropenia in adults: key points and new challenges: Committee of Neoplastic Supportive-Care (CONS), China Anti-Cancer Association Committee of Clinical Chemotherapy, China Anti-Cancer Association.
Ba Y; Shi Y; Jiang W; Feng J; Cheng Y; Xiao L; Zhang Q; Qiu W; Xu B; Xu R; Shen B; Luo Z; Xie X; Chang J; Wang M; Li Y; Shuang Y; Niu Z; Liu B; Zhang J; Zhang L; Yao H; Xie C; Huang H; Liao W; Chen G; Zhang X; An H; Deng Y; Gong P; Xiong J; Yao Q; An X; Chen C; Shi Y; Wang J; Wang X; Wang Z; Xing P; Yang S; Zhou C
Cancer Biol Med; 2020 Nov; 17(4):896-909. PubMed ID: 33299642
[TBL] [Abstract][Full Text] [Related]
7. Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO).
Kochanek M; Schalk E; von Bergwelt-Baildon M; Beutel G; Buchheidt D; Hentrich M; Henze L; Kiehl M; Liebregts T; von Lilienfeld-Toal M; Classen A; Mellinghoff S; Penack O; Piepel C; Böll B
Ann Hematol; 2019 May; 98(5):1051-1069. PubMed ID: 30796468
[TBL] [Abstract][Full Text] [Related]
8. A comparison of ED and direct admission care of cancer patients with febrile neutropenia.
Owolabi DK; Rowland R; King L; Miller R; Hegde GG; Shang J; Lister J; Venkat A
Am J Emerg Med; 2015 Jul; 33(7):966-9. PubMed ID: 25959844
[TBL] [Abstract][Full Text] [Related]
9. Does a neutropenic diet reduce adverse outcomes in patients undergoing chemotherapy?
Heng MS; Barbon Gauro J; Yaxley A; Thomas J
Eur J Cancer Care (Engl); 2020 Jan; 29(1):e13155. PubMed ID: 31441568
[TBL] [Abstract][Full Text] [Related]
10. CISNE versus MASCC: Identifying low risk febrile neutropenic patients.
Mohindra R; Mathew R; Yadav S; Aggarwal P
Am J Emerg Med; 2020 Nov; 38(11):2259-2263. PubMed ID: 31864874
[TBL] [Abstract][Full Text] [Related]
11. Application of the MASCC and CISNE Risk-Stratification Scores to Identify Low-Risk Febrile Neutropenic Patients in the Emergency Department.
Coyne CJ; Le V; Brennan JJ; Castillo EM; Shatsky RA; Ferran K; Brodine S; Vilke GM
Ann Emerg Med; 2017 Jun; 69(6):755-764. PubMed ID: 28041827
[TBL] [Abstract][Full Text] [Related]
12. Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia.
Ko BS; Ahn S; Lee YS; Kim WY; Lim KS; Lee JL
Support Care Cancer; 2015 Sep; 23(9):2799-804. PubMed ID: 25663578
[TBL] [Abstract][Full Text] [Related]
13. Performance of a modified MASCC index score for identifying low-risk febrile neutropenic cancer patients.
de Souza Viana L; Serufo JC; da Costa Rocha MO; Costa RN; Duarte RC
Support Care Cancer; 2008 Jul; 16(7):841-6. PubMed ID: 17960431
[TBL] [Abstract][Full Text] [Related]
14. Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score.
Uys A; Rapoport BL; Anderson R
Support Care Cancer; 2004 Aug; 12(8):555-60. PubMed ID: 15197637
[TBL] [Abstract][Full Text] [Related]
15. Neutropenic sepsis.
Forsyth N
Nurs Stand; 2017 Mar; 31(27):64-65. PubMed ID: 28247775
[TBL] [Abstract][Full Text] [Related]
16. Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department.
Lynn JJ; Chen KF; Weng YM; Chiu TF
Hematol Oncol; 2013 Dec; 31(4):189-96. PubMed ID: 23303687
[TBL] [Abstract][Full Text] [Related]
17. [Mortality of hematology-oncology patients with neutropenia in intensivecare].
Suárez I; Böll B; Shimabukuro-Vornhagen A; Michels G; von Bergwelt-Baildon M; Kochanek M
Med Klin Intensivmed Notfmed; 2016 Mar; 111(2):84-91. PubMed ID: 25994843
[TBL] [Abstract][Full Text] [Related]
18. Neutropenic sepsis: prevention, identification and treatment.
Warnock C
Nurs Stand; 2016 Apr; 30(35):51-60. PubMed ID: 27191320
[TBL] [Abstract][Full Text] [Related]
19. Validation of the Clinical Index of Stable Febrile Neutropenia (CISNE) model in febrile neutropenia patients visiting the emergency department. Can it guide emergency physicians to a reasonable decision on outpatient vs. inpatient treatment?
Moon H; Choi YJ; Sim SH
PLoS One; 2018; 13(12):e0210019. PubMed ID: 30596803
[TBL] [Abstract][Full Text] [Related]
20. Can mortality of cancer patients with fever and neutropenia be improved?
Thursky KA; Worth LJ
Curr Opin Infect Dis; 2015 Dec; 28(6):505-13. PubMed ID: 26374951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
